Multiple studies in tumor cells of different origin have shown that EFNA1 treatment leads to increased tyrosine phosphorylation of EphA2, e.g., at Y588 with a concomitant decrease in phosphorylation of EphA2 at S897 [37,40,41]. The gene discussed is EPHA2; the disease is neoplasm.